U.S. IPO Week Ahead: IPO Market Readies December Deals

|
Includes: AXNX, DMAC, LEGH, MRNA, NFE, ORTX, RVLV, THOR, TWST, UTC
by: Renaissance Capital IPO Research

Following the short Thanksgiving week, the IPO market is preparing for some of the year's final launches.

Companies still have a narrow window on Monday and Tuesday to submit initial filings and still price before year-end, but most of 2018's remaining deals are in the pipeline.

Five companies become eligible to schedule IPOs during the week ahead: biotech giant Moderna (NASDAQ:MRNA), oil and gas company New Fortress Energy (NFE), manufactured home company Legacy Housing (LEGH), preclinical immunotherapy biotech Synthorx (NASDAQ:THOR), and micro-cap biotech DiaMedica Therapeutics (DMAC). After updating its financials this past week, online fashion retailer Revolve Group (RVLV) may also launch.

Just one small IPO may price this week, Uranium Trading Corp. (UTC), an investment vehicle for uranium.

Street Research is expected for three recent IPOs on Monday: Axonics Modulation (NASDAQ:AXNX), Orchard Therapeutics (NASDAQ:ORTX), and Twist Bioscience (NASDAQ:TWST).

Editor's Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.